Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Ongoing drug recalls - open right now

Every FDA drug recall whose status is still Ongoing: the firm is still removing product from the market, or the FDA has not yet closed the file. Some were opened years ago and never formally terminated, so check the initiation date as well as the status.

2,760 recalls, newest first.

Class II · Moderate risk

Admelog Solostar

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Ongoing Temperature excursion Sanofi-Aventis U.S. LLC NDC 0024-5925-00 D-0925-2018
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Elevated number of units with out of specification results for leak rate

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0793-2017
Class II · Moderate risk

Ventolin HFA

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0626-2017
Class I · High risk

EpiPen Jr. 2-Pak

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Ongoing Packaging defect Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0691-2017
Class I · High risk

EpiPen 2-Pak

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Ongoing Packaging defect Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0690-2017
Class II · Moderate risk

Double Hyaluronic 1000

Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.

Ongoing Microbial contamination Signature Club A Ltd D-0662-2017
Class III · Low risk

INOVA (benzoyl peroxide)

Subpotent Drug: Product label claim is 4% Benzoyl Peroxide, Initial Stability testing showed variation within the lot outside of product specifications.

Ongoing Wrong potency / content Cipher Pharmaceuticals US LLC NDC 68712-013-01 D-0237-2017

Recalls by year